Want to get involved in celiac disease research? It’s time to take action.
The TEV-CeD2 Study is a phase 2 clinical trial testing the investigational drug TEV-53408 for celiac disease.
TEV-53408 is an antibody designed to block interleukin-15 with the goal of reducing intestinal damage and symptoms that occur when people with celiac disease ingest gluten.
This research study aims to find out if a single injection of the study drug is safe and effective in adults with celiac disease compared to a placebo.
Compensation for time and travel may be available.
Requirements:
- 18-65 years old
- Diagnosed with celiac disease for 12+ months
- On a gluten-free diet for 12+ months
Locations:
- Atlanta, GA
- Clinton Township, MI
- Colorado Springs, CO
- Greenville, NC
- Inverness, FL
- Marrero, LA
- Miami Lakes, FL
- Ogden, UT
- Winston-Salem, NC
- Wyoming, MI
Potential Benefits of Participation:
- Opportunity to access a new investigational drug
- Receive study-related medical care at no cost
- Play a role in advancing celiac disease research
Learn more: tevstudy.celiac.org
Find out if you may qualify: iqualify.celiac.org
New Phase 2 Clinical Trial: TEV-CeD2 Study